Heart Health
Pfizer's PCSK9 Inhibitor Bococizumab Put to the Test in High-Risk Hyperlipidemia
A Phase 3 trial examines whether bococizumab slashes LDL in statin-treated patients at elevated cardiovascular risk.
Clinical Trial
Jun 8, 2026 0
Results for "BPC-157 Peptide"
20 articles
Cancer Research
Pfizer Tests Novel CD47-PD-L1 Bispecific Antibody in Advanced Solid Tumors
A first-in-human Phase 1 trial evaluates PF-07257876, a dual-checkpoint bispecific antibody targeting both CD47 and PD-L1, in hard-to-treat cancers.
Clinical Trial
May 21, 2026 0
Heart Health
Chinese PCSK9 Inhibitor Trial Tests IBI306 for High-Risk Cholesterol Patients
Phase 3 trial of IBI306, a PCSK9 inhibitor, tests LDL-C reduction in Chinese adults with high cardiovascular risk on statin therapy.
Clinical Trial
Jun 7, 2026 0
Cancer Research
Amgen's PSMA Bispecific T-Cell Engager Acapatamab Tested in Advanced Prostate Cancer
Phase 1 trial of acapatamab, a PSMA-targeting bispecific T-cell engager, enrolls 212 men with metastatic castration-resistant prostate cancer.
Clinical Trial
May 13, 2026 0
Supplements
Collagen Peptides Added to Calcium and Vitamin D Boost Bone Health in Postmenopausal Women
A completed RCT tests whether adding collagen peptides to standard calcium and vitamin D supplementation improves bone density and remodeling markers in women with osteopenia.
Clinical Trial
May 20, 2026 0
Cancer Research
Pfizer Terminates Phase 1 Trial of Novel Anti-PD-1/IL-15 Fusion Protein in Solid Tumors
Pfizer's first-in-human trial of PF-07209960, a dual-action immunotherapy fusion protein, was terminated after enrolling 37 patients.
Clinical Trial
May 14, 2026 0
Longevity & Aging
Growth Hormone Booster MK-677 Tested for Anti-Aging Effects in Older Adults
12-month trial examined whether oral MK-677 could restore youthful growth hormone levels and improve body composition in healthy seniors.
Clinical Trial
Mar 28, 2026 0
Regenerative Medicine
Platelet-Rich Plasma Shows Promise for Knee Osteoarthritis Pain Relief
150-person trial tests whether PRP injections can reduce knee pain and improve function better than placebo in osteoarthritis patients.
Clinical Trial
Mar 28, 2026 0
Brain Health
Oral All-D-Peptide Contraloid Advances to Human Safety Trial for Alzheimer's
A first-in-human multiple-ascending-dose trial tests Contraloid, an oral peptide designed to disassemble toxic amyloid-beta oligomers linked to Alzheimer's disease.
Clinical Trial
Jun 17, 2026 0
Regenerative Medicine
Platelet Rich Plasma Shows Promise for Chronic Lower Back Pain Relief
Military study tests regenerative PRP injections against placebo for facet joint pain in 91 participants.
Clinical Trial
Mar 28, 2026 0
Hormones
Ghrelin Receptor Agonist Shows Promise for Muscle and Bone Health in Older Adults
Small trial tests hormone-based therapy to combat age-related muscle and bone loss in vulnerable adults.
Clinical Trial
Mar 28, 2026 0
Supplements
Collagen Plus Exercise Boosts Function and Strength in Adults Over 55
University study tests whether collagen peptides combined with exercise improve muscle mass, bone health, and quality of life in older adults.
Clinical Trial
Mar 29, 2026 0
Regenerative Medicine
Stem Cell Therapy Shows Promise for Severe Knee Osteoarthritis in 140-Patient Study
Adipose-derived stem cells combined with platelet-rich plasma evaluated for treating moderate to severe knee osteoarthritis over 2 years.
Clinical Trial
Mar 29, 2026 1
Regenerative Medicine
Biodegradable Temporizing Matrix Shows Promise for Deep Burn Wound Healing
A completed multicenter feasibility trial evaluates BTM, a novel biodegradable scaffold, for treating serious deep burn injuries.
Clinical Trial
Jun 8, 2026 0
Brain Health
First Human Trial of Oral D-Peptide Drug Targeting Alzheimer's Toxic Oligomers Completed
Contraloid acetate, an oral all-D-peptide designed to disassemble toxic amyloid-beta oligomers, completed its first-in-human safety trial in 40 healthy volunteers.
Clinical Trial
Jun 12, 2026 0
Autoimmune & Arthritis
Placental Stem Cell Secretome Tested as GvHD Treatment in Phase 3 Trial
A completed Phase 3 trial tests placental MSC secretome injections against placebo in 60 GvHD patients at an Iranian hospital.
Clinical Trial
May 12, 2026 0
Heart Health
Pelacarsen Targets Lp(a) in Black and Hispanic Americans With Heart Disease
A completed Phase IIIb trial tests whether pelacarsen can safely lower Lp(a) in historically underrepresented cardiovascular disease populations.
Clinical Trial
May 27, 2026 0
Regenerative Medicine
Blood-Derived Stem Cell Therapy Shows Promise for Critical Limb Ischemia
Autologous stem cell injections tested in patients with severe leg circulation problems who had no surgical options.
Clinical Trial
Mar 29, 2026 1
Longevity & Aging
Growth Hormone Booster Trial in Frail Elderly Shows Mixed Results After Early Termination
Pfizer's 24-month study of oral growth hormone secretagogue CP-424,391 in 396 at-risk elderly adults was terminated early.
Clinical Trial
Mar 28, 2026 0
Regenerative Medicine
PRP Injections Show Promise for Shoulder Arthritis Pain Relief
Clinical trial tests platelet-rich plasma therapy for shoulder osteoarthritis in 91 patients over 5 months.
Clinical Trial
Mar 28, 2026 0
Page 1 of 2Next